Camp4 (CAMP) CMO Yuri Maricich Buys 6,551 Shares

What Happened
Yuri Maricich, Chief Medical Officer of Camp4 Therapeutics (CAMP), acquired 6,551 shares on August 3, 2026 in a private placement purchase at $1.65 per share, for a total purchase price of $10,809. This was a purchase (insider acquisition), which many investors view as a more informative signal than routine sales.

Key Details

• Transaction date: August 3, 2026; filing date: August 5, 2026 (filed within the typical 2-business-day Form 4 window).
• Transaction type/code: Purchase (P) — private placement (second closing).
• Price and volume: 6,551 shares at $1.65 per share; total value $10,809.
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Footnote: Acquisition occurred in the second closing of a private placement under a Securities Purchase Agreement dated Sept 9, 2025, as amended Aug 3, 2026; the offering included institutional investors and certain directors, employees, and consultants.

Context
This was a private placement (not an open-market buy) executed as part of a structured financing; such transactions can include participation by company insiders alongside institutional investors. The dollar amount is relatively small, so while it is an insider purchase, it may reflect participation in the financing rather than a large personal investment signal.